UNSPSC 51382800: Nonsteroidal anti inflammatory glycolates

Nonsteroidal anti inflammatory drugs made from Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon.

UNSPSC 51382800 Nonsteroidal anti inflammatory glycolates is a Class code that shows significant mismatch between its nominal scope and the work actually being solicited under it in state and local procurement. Recent opportunities tagged to this code involve naloxone procurement, direct-to-manufacturer pharmacy programs, and multi-source generic pharmaceuticals and OTC products—none of which are nonsteroidal anti-inflammatory glycolates. The code does not appear to reflect the pharmaceutical product categories that state and local buyers are actively purchasing; the tagging appears to be a classification error rather than a signal of activity in the specific drug class the code describes.

The three recent opportunities span a county health department (Seminole County, Florida), a state health agency (Texas Health and Human Services Commission), and a multistate cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance, covering state and local facilities across multiple states including Oregon). Seminole County is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding (IFB 60459723LAS, due July 26, 2023); Texas HHS issued an exploratory Request for Information on direct-to-manufacturer prescription programs (RFI HHS0017013, April 3, 2026); and MMCAP posted an RFP for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities, with proposals due March 26, 2026. These solicitations do not substantiate demand for the nonsteroidal anti-inflammatory glycolate product line, and the code's recent activity record does not support a reliable basis for market assessment under its stated scope.